[Letterhead
of BioVeris Corporation]
July
26 ,
2007
Withdrawal
of Post-Effective Amendment No. 1 to Registration Statement on Form
S-8
Registration
Number 333-113173
Filed
July
12, 2007
VIA
EDGAR
Securities
and Exchange Commission
100
F
Street, N.E.
Washington,
D.C. 20549
Ladies
and
Gentlemen:
Pursuant
to Rule 477 of the Securities Act of 1933, as amended, we hereby withdraw the
above referenced Registration Statement Post-Effective Amendment (the
“Registration Statement Post-Effective Amendment”) of BioVeris Corporation, a
Delaware company (“BioVeris”), and hereby request that an order consenting to
the withdrawal be entered by the Securities and Exchange Commission (the
“Commission”). The Registration Statement Post-Effective Amendment is being
withdrawn due to the fact that the Registration Statement Post-Effective
Amendment was filed via EDGAR under an incorrect form type, the correct form
type for this Registration Statement Post-Effective Amendment is “S-8 POS”.
BioVeris further advises the Commission that no securities included in the
Registration Statement Post-Effective Amendment have been sold or otherwise
distributed.
Your
assistance in this matter is greatly appreciated. Please feel free to contact
Paul D. Hodgdon at (212) 450-4502 at Davis Polk & Wardwell with any
questions you may have.
|
Sincerely,
|
| |
| |
|
BIOVERIS
CORPORATION
|
| |
|
/s/
Steve A. Oldham
|
| |
|
Steve
A. Oldham
|
|
Vice
President and Assistant Secretary
|